Valuation Update With 7 Day Price Move • 15h
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to €65.40, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in Germany. Total returns to shareholders of 38% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €84.13 per share. Upcoming Dividend • May 07
Upcoming dividend of €1.90 per share Eligible shareholders must have bought the stock before 14 May 2026. Payment date: 19 May 2026. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.7%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (3.7%). Reported Earnings • Apr 06
Full year 2025 earnings released: EPS: €5.24 (vs €5.84 in FY 2024) Full year 2025 results: EPS: €5.24 (down from €5.84 in FY 2024). Revenue: €512.1m (up 7.4% from FY 2024). Net income: €26.4m (down 10% from FY 2024). Profit margin: 5.2% (down from 6.2% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 8% per year. Declared Dividend • Apr 02
Dividend of €1.90 announced Dividend of €1.90 is the same as last year. Ex-date: 14th May 2026 Payment date: 19th May 2026 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth The dividend has increased by an average of 6.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to decline by 4.3% over the next 3 years. However, it would need to fall by 66% to increase the payout ratio to a potentially unsustainable range. New Risk • Mar 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.8% per year for the foreseeable future. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). New Risk • Feb 20
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Feb 04
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €83.50, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 65% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €41.87 per share. Price Target Changed • Sep 10
Price target increased by 11% to €84.50 Up from €76.00, the current price target is an average from 2 analysts. New target price is 15% above last closing price of €73.50. Stock is up 51% over the past year. The company is forecast to post earnings per share of €5.53 for next year compared to €5.84 last year. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €77.00, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €70.71 per share. Reported Earnings • Aug 19
First half 2025 earnings released: EPS: €2.77 (vs €2.45 in 1H 2024) First half 2025 results: EPS: €2.77 (up from €2.45 in 1H 2024). Revenue: €251.8m (up 3.9% from 1H 2024). Net income: €13.9m (up 13% from 1H 2024). Profit margin: 5.5% (up from 5.1% in 1H 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 4% per year. Buy Or Sell Opportunity • Jul 31
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 12% to €69.50. The fair value is estimated to be €57.49, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 5.1%. For the next 3 years, revenue is forecast to grow by 4.4% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period. Price Target Changed • May 23
Price target increased by 8.6% to €76.00 Up from €70.00, the current price target is an average from 2 analysts. New target price is 25% above last closing price of €61.00. Stock is up 27% over the past year. The company is forecast to post earnings per share of €5.39 for next year compared to €5.84 last year. Upcoming Dividend • May 07
Upcoming dividend of €1.90 per share Eligible shareholders must have bought the stock before 14 May 2025. Payment date: 16 May 2025. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.4%). Lower than average of industry peers (3.9%). Buy Or Sell Opportunity • Apr 08
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 12% to €55.50. The fair value is estimated to be €44.47, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 5.1%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 1.6% per annum over the same time period. Declared Dividend • Apr 04
Dividend increased to €1.90 Dividend of €1.90 is 19% higher than last year. Ex-date: 14th May 2025 Payment date: 16th May 2025 Dividend yield will be 3.5%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (21% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to decline by 6.8% over the next 2 years. However, it would need to fall by 62% to increase the payout ratio to a potentially unsustainable range. Duyuru • Apr 04
Uzin Utz SE announces Annual dividend, payable on May 16, 2025 Uzin Utz SE announced Annual dividend of EUR 1.9000 per share payable on May 16, 2025, ex-date on May 14, 2025 and record date on May 15, 2025. Duyuru • Apr 03
Uzin Utz SE, Annual General Meeting, May 13, 2025 Uzin Utz SE, Annual General Meeting, May 13, 2025, at 10:30 W. Europe Standard Time. Reported Earnings • Apr 02
Full year 2024 earnings: EPS exceeds analyst expectations Full year 2024 results: EPS: €5.84 (up from €4.48 in FY 2023). Revenue: €483.7m (flat on FY 2023). Net income: €29.4m (up 30% from FY 2023). Profit margin: 6.1% (up from 4.7% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 14%. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 9% per year. New Risk • Apr 02
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 3.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. New Risk • Mar 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company. Price Target Changed • Feb 26
Price target increased by 13% to €70.00 Up from €62.00, the current price target is provided by 1 analyst. New target price is 20% above last closing price of €58.50. Stock is up 21% over the past year. The company is forecast to post earnings per share of €5.12 for next year compared to €4.48 last year. Valuation Update With 7 Day Price Move • Feb 24
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €57.50, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 20% over the past three years. Reported Earnings • Aug 18
First half 2024 earnings released: EPS: €2.45 (vs €2.19 in 1H 2023) First half 2024 results: EPS: €2.45 (up from €2.19 in 1H 2023). Revenue: €242.3m (down 1.0% from 1H 2023). Net income: €12.4m (up 12% from 1H 2023). Profit margin: 5.1% (up from 4.5% in 1H 2023). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year. Upcoming Dividend • May 16
Upcoming dividend of €1.60 per share Eligible shareholders must have bought the stock before 23 May 2024. Payment date: 27 May 2024. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (4.9%). Price Target Changed • Apr 05
Price target increased by 15% to €60.00 Up from €52.00, the current price target is provided by 1 analyst. New target price is 22% above last closing price of €49.00. Stock is down 9.3% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €4.48 last year. Reported Earnings • Mar 30
Full year 2023 earnings released: EPS: €4.48 (vs €5.02 in FY 2022) Full year 2023 results: EPS: €4.48 (down from €5.02 in FY 2022). Revenue: €484.8m (flat on FY 2022). Net income: €22.6m (down 11% from FY 2022). Profit margin: 4.7% (down from 5.2% in FY 2022). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Duyuru • Mar 29
Uzin Utz SE, Annual General Meeting, May 22, 2024 Uzin Utz SE, Annual General Meeting, May 22, 2024. Location: Donauhalle, Ulm Ulm Germany New Risk • Mar 15
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 30
First half 2023 earnings released: EPS: €2.19 (vs €2.68 in 1H 2022) First half 2023 results: EPS: €2.19 (down from €2.68 in 1H 2022). Revenue: €244.7m (flat on 1H 2022). Net income: €11.0m (down 19% from 1H 2022). Profit margin: 4.5% (down from 5.5% in 1H 2022). Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 6% per year. Price Target Changed • Nov 16
Price target decreased to €68.00 Down from €95.00, the current price target is provided by 1 analyst. New target price is 37% above last closing price of €49.50. Stock is down 42% over the past year. The company posted earnings per share of €6.53 last year. Price Target Changed • Nov 07
Price target decreased to €68.00 Down from €95.00, the current price target is provided by 1 analyst. New target price is 54% above last closing price of €44.10. Stock is down 49% over the past year. The company posted earnings per share of €6.53 last year. Valuation Update With 7 Day Price Move • Sep 20
Investor sentiment deteriorated over the past week After last week's 17% share price decline to €43.60, the stock trades at a trailing P/E ratio of 8.3x. Average forward P/E is 10x in the Chemicals industry in Germany. Total loss to shareholders of 10% over the past three years. Reported Earnings • Aug 29
First half 2022 earnings released: EPS: €0 (vs €3.98 in 1H 2021) First half 2022 results: EPS: €0 (down from €3.98 in 1H 2021). Revenue: €246.5m (up 11% from 1H 2021). Net income: €13.5m (down 33% from 1H 2021). Profit margin: 5.5% (down from 9.1% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.7%, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Buying Opportunity • Jun 10
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 21%. The fair value is estimated to be €74.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.3% over the last 3 years. Earnings per share has grown by 34%. Upcoming Dividend • May 11
Upcoming dividend of €1.80 per share Eligible shareholders must have bought the stock before 18 May 2022. Payment date: 20 May 2022. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (5.2%). Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment deteriorated over the past week After last week's 15% share price decline to €67.00, the stock trades at a trailing P/E ratio of 8.7x. Average forward P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 48% over the past three years. Price Target Changed • Nov 17
Price target increased to €100.00 Up from €89.00, the current price target is provided by 1 analyst. New target price is 16% above last closing price of €86.00. Stock is up 62% over the past year. The company posted earnings per share of €5.76 last year. Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment improved over the past week After last week's 19% share price gain to €92.00, the stock trades at a trailing P/E ratio of 22.5x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 65% over the past three years. Reported Earnings • Aug 28
First half 2020 earnings released: EPS €2.01 (vs €2.14 in 1H 2019) The company reported a poor first half result with weaker earnings and profit margins, although revenues were flat. First half 2020 results: Revenue: €186.9m (flat on 1H 2019). Net income: €10.1m (down 5.9% from 1H 2019). Profit margin: 5.4% (down from 5.8% in 1H 2019). Price Target Changed • Aug 06
Price target increased to €95.00 Up from €85.00, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €76.50. Stock is up 38% over the past year. Upcoming Dividend • May 20
Upcoming dividend of €1.55 per share Eligible shareholders must have bought the stock before 27 May 2021. Payment date: 31 May 2021. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%). Price Target Changed • Feb 27
Price target raised to €85.00 Up from €78.00, the current price target is provided by 1 analyst. The new target price is 18% above the current share price of €72.00. As of last close, the stock is up 22% over the past year. Valuation Update With 7 Day Price Move • Feb 26
Investor sentiment improved over the past week After last week's 19% share price gain to €72.00, the stock is trading at a trailing P/E ratio of 17.6x, up from the previous P/E ratio of 14.8x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 19%. Is New 90 Day High Low • Feb 16
New 90-day high: €60.40 The company is up 14% from its price of €53.00 on 18 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 15% over the same period. Price Target Changed • Feb 04
Price target raised to €78.00 Up from €70.50, the current price target is provided by 1 analyst. The new target price is 33% above the current share price of €58.60. As of last close, the stock is down 3.1% over the past year. Is New 90 Day High Low • Jan 13
New 90-day high: €58.40 The company is up 2.0% from its price of €57.20 on 14 October 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. Is New 90 Day High Low • Oct 26
New 90-day low: €51.40 The company is down 4.0% from its price of €53.60 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period. Is New 90 Day High Low • Sep 19
New 90-day high: €57.20 The company is up 6.0% from its price of €54.00 on 19 June 2020. The German market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.